1. Anemia2. Patients with contraindications to the use of IOR® LEUKOCIM.3. Patients who have taken amiodarone in the last 3 months, which can cause pulmonary fibrosis.4. Patients with malignant tumor in the last 5 years.5. Patients with decompensated heart and kidney disease.6. Patients with liver disease whose presence of enzyme values 2 times above the upper level of the range of normal values is demonstrated in the blood chemistry.7. Patients who have ultrasound images that require further study for diagnosis.8. Pregnant women 9. Patients with severe lung infection who need anti-infective treatment.10. Patients with proven viral infections or positive serology.

1. Anemia2. Patients with contraindications to the use of IOR® LEUKOCIM.3. Patients who have taken amiodarone in the last 3 months, which can cause pulmonary fibrosis.4. Patients with malignant tumor in the last 5 years.5. Patients with decompensated heart and kidney disease.6. Patients with liver disease whose presence of enzyme values 2 times above the upper level of the range of normal values is demonstrated in the blood chemistry.7. Patients who have ultrasound images that require further study for diagnosis.8. Pregnant women 9. Patients with severe lung infection who need anti-infective treatment.10. Patients with proven viral infections or positive serology.

1. Anemia 2. Patients with contraindications to the use of IOR(R) LEUKOCIM. 3. Patients who have taken amiodarone in the last 3 months, which can cause pulmonary fibrosis. 4. Patients with malignant tumor in the last 5 years. 5. Patients with decompensated heart and kidney disease. 6. Patients with liver disease whose presence of enzyme values 2 times above the upper level of the range of normal values is demonstrated in the blood chemistry. 7. Patients who have ultrasound images that require further study for diagnosis. 8. Pregnant women 9. Patients with severe lung infection who need anti-infective treatment. 10. Patients with proven viral infections or positive serology.

1. Anemia 2. Patients with contraindications to the use of IOR(R) LEUKOCIM. 3. Patients who have taken amiodarone in the last 3 months, which can cause pulmonary fibrosis. 4. Patients with malignant tumor in the last 5 years. 5. Patients with decompensated heart and kidney disease. 6. Patients with liver disease whose presence of enzyme values 2 times above the upper level of the range of normal values is demonstrated in the blood chemistry. 7. Patients who have ultrasound images that require further study for diagnosis. 8. Pregnant women 9. Patients with severe lung infection who need anti-infective treatment. 10. Patients with proven viral infections or positive serology.